Published date: 30 April 2021

This notice was replaced on 30 April 2021

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 30 April 2021)

Awarded contract - This means that the contract has been awarded to a supplier.


Contract summary

Industry

  • Vaccines - 33651600

Location of contract

RG1 7EB

Value of contract

£0

Procurement reference

CF-0169500D0O000000rwimUAA1

Published date

30 April 2021

Closing date

29 October 2020

Closing time

11am

Contract start date

1 April 2021

Contract end date

31 March 2023

Contract type

Supply contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The supply of herpes zoster (shingles) vaccine, deliveries will be required from 1 April 2021 to 31 March 2022
Contract has the option to be extended up to an additional 9 months
Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier.

More information

Links

Award information

Awarded date

30 March 2021

Contract start date

1 April 2021

Contract end date

31 March 2023

Total value of contract

£1

This contract was awarded to 1 supplier.

Merck Sharpe & Dohme (UK) Limited

Address

120 Moorgate EC2M 6UR

Reference

None

About the buyer

Contact name

Lynne Nichols

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
GB

Email

lynne.nichols@dhsc.gov.uk